Related Experiment Video
Updated: May 22, 2025
High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor
Published on: June 14, 2018
Comprehensive genomic dependency landscape of a human colon cancer organoid
Sana Khalili1, Atefeh Mohseninia2, Changlong Liu2
1University of South Carolina, Columbia, SC, US. s.khalili1367@gmail.com.
Abstract:
Identifying genetic dependencies in human colon cancer could help identify effective treatment strategies. Genome-wide CRISPR-Cas9 dropout screens have the potential to reveal genetic dependencies, some of which could be exploited as therapeutic targets using existing drugs. In this study, we comprehensively characterized genetic dependencies present in a colon cancer organoid avatar, and validated tumor-specific selectivity of select pharmacologic agents. We conducted a genome-wide CRISPR dropout screen to elucidate the genetic dependencies that interacted with select driver somatic mutations. We found distinct genetic dependencies that interacted with WNT, MAPK, PI3K, TP53, and mismatch repair pathways and validated targets that could be exploited as treatments for this specific subtype of colon cancer. These findings demonstrate the utility of functional genomic screening in the context of personalized medicine.
Insights
This study used CRISPR screens in colon cancer organoids to find genetic dependencies linked to key cancer pathways. These findings identify potential therapeutic targets for personalized colon cancer treatments.
Area of Science:
- Genomics
- Cancer Biology
- Pharmacology
Background:
- Identifying genetic dependencies in human colon cancer is crucial for developing effective treatment strategies.
- Genome-wide CRISPR-Cas9 dropout screens offer a powerful method to uncover these dependencies, potentially revealing druggable targets.
Purpose of the Study:
- To comprehensively characterize genetic dependencies in a colon cancer organoid model.
- To validate the tumor-specific selectivity of pharmacologic agents targeting identified dependencies.
- To elucidate genetic dependencies interacting with key driver somatic mutations in colon cancer.
Main Methods:
- Utilized genome-wide CRISPR-Cas9 dropout screens in colon cancer organoids.
- Analyzed genetic dependencies associated with WNT, MAPK, PI3K, TP53, and mismatch repair pathways.
- Validated the efficacy and selectivity of pharmacologic agents against identified targets.
Main Results:
- Identified distinct genetic dependencies interacting with WNT, MAPK, PI3K, TP53, and mismatch repair pathways.
- Validated specific pharmacologic agents as potential treatments for colon cancer subtypes.
- Demonstrated the utility of functional genomic screening for personalized medicine.
Conclusions:
- Functional genomic screening, specifically CRISPR dropout screens, is effective in identifying colon cancer genetic dependencies.
- These dependencies represent actionable therapeutic targets for personalized colon cancer treatment strategies.
- The study highlights the potential for exploiting identified targets with existing drugs.
More Related Videos
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...